DorsaVi (ASX:DVL) 3-Year EPS without NRI Growth Rate: 20.60% (As of Dec. 2025) — 30% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is DorsaVi 3-Year EPS without NRI Growth Rate?

DorsaVi ASX:DVL 3-Year EPS without NRI Growth Rate is 20.60% as of Dec. 2025, which is 30% below its 10-year median of 29.50. The stock has 4 warning signs investors should review. Among 1,901 Hardware companies, DorsaVi ranks better than 72.91% on this metric.

DorsaVi's EPS without NRI for the six months ended in Dec. 2025 was A$-0.00.

During the past 3 years, the average EPS without NRI Growth Rate was 20.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 39.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was 30.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 12 years, the highest 3-Year average EPS without NRI Growth Rate of DorsaVi was 50.50% per year. The lowest was -14.50% per year. And the median was 29.50% per year.


DorsaVi  (ASX:DVL) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


DorsaVi 3-Year EPS without NRI Growth Rate Related Terms


ASX:DVL vs GRMN, COHR, KEYS: 3-Year EPS without NRI Growth Rate Comparison

For the Scientific & Technical Instruments subindustry, DorsaVi's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DorsaVi 3-Year EPS without NRI Growth Rate vs Hardware Industry

For the Hardware industry and Technology sector, DorsaVi's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where DorsaVi's 3-Year EPS without NRI Growth Rate falls into.



DorsaVi 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

What does a 3-Year EPS without NRI Growth Rate of 20.60% mean?
DorsaVi (ASX:DVL) has a 3-Year EPS without NRI Growth Rate of 20.60% as of Dec. 2025. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for DorsaVi and its competitors. This is 30% below median its historical median of 29.50. According to the industry distribution chart, DorsaVi ranks #515 out of 1901 companies in the Hardware industry, placing it in the top 27.1%.
Is DorsaVi's 3-Year EPS without NRI Growth Rate too high?
DorsaVi's current 3-Year EPS without NRI Growth Rate of 20.60% is 30% below median its 10-year median of 29.50. The Hardware industry median 3-Year EPS without NRI Growth Rate is 1.80. DorsaVi's value of 20.60% is 1044.4% above this industry median. Based on the distribution chart, DorsaVi ranks #515 out of 1901 companies in the Hardware industry, which is above the industry midpoint.
How does DorsaVi's 3-Year EPS without NRI Growth Rate compare to GRMN and COHR?
According to the Hardware industry distribution chart, DorsaVi ranks #515 out of 1901 companies for 3-Year EPS without NRI Growth Rate. This puts DorsaVi in the upper half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 1.80. DorsaVi's value of 20.60% is 1044.4% above this benchmark. While the company's 10-year median is 29.50 vs. the industry median of 1.80, DorsaVi has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Hardware company?
The median 3-Year EPS without NRI Growth Rate among Hardware companies is 1.80, based on 1,901 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DorsaVi's current 3-Year EPS without NRI Growth Rate of 20.60% is 1044.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for DorsaVi and its competitors. For the Hardware industry, the median 3-Year EPS without NRI Growth Rate is 1.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DorsaVi's current 3-Year EPS without NRI Growth Rate is 20.60%, which is 30% below median its own 10-year median of 29.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DorsaVi stock overvalued right now?
DorsaVi (ASX:DVL) has a current 3-Year EPS without NRI Growth Rate of 20.60%. The current 3-Year EPS without NRI Growth Rate is 20.60%, which is 30% below median its 10-year median of 29.50 and 1044.4% above the Hardware industry median of 1.80. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For DorsaVi (ASX:DVL), the current 3-Year EPS without NRI Growth Rate is 20.60% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DorsaVi Business Description

Address 11-13 Milgate Street, Unit 3, Oakleigh South, Melbourne, VIC, AUS, 3167
DorsaVi Ltd is engaged in the development and sale of motion analysis technologies. Its technologies are commercialized via license, sale, or fixed-fee consultancy. The company makes wearable sensors, software, and sophisticated algorithms that measure movement and muscle activation at around 200 frames per second. The company's products include ViSafe (Workplace), ViMove (Clinic), and others. The firm operates in two reportable segments: Clinical and Workplace. The majority of its revenue is generated from the Clinical segment. Geographically, the company derives maximum revenue from the United States of America, and the rest from Australia and Europe.